AACR 2024: EpiBiologics Advances Degraders of Membrane-Bound Proteins

https://www.genengnews.com/topics/cancer/aacr-2024-epibiologics-advances-degraders-of-membrane-bound-proteins/

Previous
Previous

EpiBiologics Extracellular Protein Degraders Demonstrate Robust Preclinical Anti-tumor Activity and Survival Benefit

Next
Next

EpiBiologics Appoints Ann Lee-Karlon as Chief Executive Officer and President, Extends Series A Financing to Over $70 Million